• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶 4(PRDX4)对胆汁淤积性肝损伤的保护作用。

Protective Effects of Peroxiredoxin 4 (PRDX4) on Cholestatic Liver Injury.

机构信息

Department of Pathology and Laboratory Medicine, Kanazawa Medical University, 1-1 Uchinada, Ishikawa 920-0293, Japan.

Department of Pathology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8544, Japan.

出版信息

Int J Mol Sci. 2018 Aug 24;19(9):2509. doi: 10.3390/ijms19092509.

DOI:10.3390/ijms19092509
PMID:30149550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6163182/
Abstract

Accumulating evidence indicates that oxidative stress plays a critical role in initiating the progression of inflammatory and fibrotic liver diseases, including cholestatic hepatitis. Peroxiredoxin 4 (PRDX4) is a secretory antioxidase that protects against oxidative damage by scavenging reactive oxygen species (ROS) in both the intracellular compartments and extracellular space. In this study, we examined the in vivo net effects of PRDX4 overexpression in a murine model of cholestasis. To induce cholestatic liver injury, we subjected C57BL/6J wild-type (WT) or human PRDX4 (hPRDX4) transgenic (Tg) mice to sham or bile duct ligation (BDL) surgery for seven days. Our results showed that the liver necrosis area was significantly suppressed in Tg BDL mice with a reduction in the severity of liver injuries. Furthermore, PRDX4 overexpression markedly reduced local and systemic oxidative stress generated by BDL. In addition, suppression of inflammatory cell infiltration, reduced proliferation of hepatocytes and intrahepatic bile ducts, and less fibrosis were also found in the liver of Tg BDL mice, along with a reduced mortality rate after BDL surgery. Interestingly, the composition of the hepatic bile acids (BAs) was more beneficial for Tg BDL mice than for WT BDL mice, suggesting that PRDX4 overexpression may affect BA metabolism during cholestasis. These features indicate that PRDX4 plays an important role in protecting against liver injury following BDL and might be a promising therapeutic modality for cholestatic diseases.

摘要

越来越多的证据表明,氧化应激在启动炎症和纤维化性肝病(包括胆汁淤积性肝炎)的进展中起着关键作用。过氧化物酶 4(PRDX4)是一种分泌型抗氧化酶,可通过清除细胞内区室和细胞外空间中的活性氧(ROS)来防止氧化损伤。在这项研究中,我们在胆汁淤积的小鼠模型中检查了 PRDX4 过表达的体内净效应。为了诱导胆汁淤积性肝损伤,我们使 C57BL/6J 野生型(WT)或人 PRDX4(hPRDX4)转基因(Tg)小鼠接受假手术或胆管结扎(BDL)手术 7 天。我们的结果表明,TgBDL 小鼠的肝坏死面积明显受到抑制,肝损伤的严重程度降低。此外,PRDX4 过表达显著降低了 BDL 引起的局部和全身氧化应激。此外,在 TgBDL 小鼠的肝脏中还发现了炎症细胞浸润的抑制、肝细胞和肝内胆管增殖的减少以及纤维化的减少,并且 BDL 手术后的死亡率降低。有趣的是,肝胆汁酸(BAs)的组成对 TgBDL 小鼠比 WTBDL 小鼠更有利,表明 PRDX4 过表达可能会影响胆汁淤积期间的 BA 代谢。这些特征表明,PRDX4 在防止 BDL 后肝损伤中起着重要作用,并且可能是胆汁淤积性疾病的有前途的治疗方式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/9c35e08c5b86/ijms-19-02509-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/fcbcf2e311d8/ijms-19-02509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/7714c429c985/ijms-19-02509-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/efb2907d8c56/ijms-19-02509-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/ebd0b8435b78/ijms-19-02509-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/5d678920f2c9/ijms-19-02509-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/cfe92eb30537/ijms-19-02509-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/b7c7fa599ac1/ijms-19-02509-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/9c35e08c5b86/ijms-19-02509-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/fcbcf2e311d8/ijms-19-02509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/7714c429c985/ijms-19-02509-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/efb2907d8c56/ijms-19-02509-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/ebd0b8435b78/ijms-19-02509-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/5d678920f2c9/ijms-19-02509-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/cfe92eb30537/ijms-19-02509-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/b7c7fa599ac1/ijms-19-02509-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a2/6163182/9c35e08c5b86/ijms-19-02509-g008.jpg

相似文献

1
Protective Effects of Peroxiredoxin 4 (PRDX4) on Cholestatic Liver Injury.过氧化物酶 4(PRDX4)对胆汁淤积性肝损伤的保护作用。
Int J Mol Sci. 2018 Aug 24;19(9):2509. doi: 10.3390/ijms19092509.
2
Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice.线粒体保护作为甘氨酸在胆汁淤积性小鼠中肝保护作用的机制。
Biomed Pharmacother. 2018 Jan;97:1086-1095. doi: 10.1016/j.biopha.2017.10.166. Epub 2017 Nov 10.
3
Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.有机阴离子转运多肽 1a1 缺失小鼠对胆汁淤积性肝损伤敏感。
Toxicol Sci. 2012 Jun;127(2):451-62. doi: 10.1093/toxsci/kfs123. Epub 2012 Mar 29.
4
Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease.过氧化物酶体增殖物激活受体4(PRDX4):其在从动脉粥样硬化到非酒精性脂肪性肝病等代谢综合征动物模型中的关键体内作用。
Pathol Int. 2018 Feb;68(2):91-101. doi: 10.1111/pin.12634. Epub 2018 Jan 17.
5
Beneficial effects of hepatic cyclooxygenase-2 expression against cholestatic injury after common bile duct ligation in mice.肝环氧合酶-2 表达对胆总管结扎后小鼠胆汁淤积性损伤的有益作用。
Liver Int. 2024 Sep;44(9):2409-2423. doi: 10.1111/liv.16004. Epub 2024 Jun 7.
6
The Association of Peroxiredoxin 4 with the Initiation and Progression of Hepatocellular Carcinoma.过氧化物酶 4 与肝细胞癌发生和进展的关系。
Antioxid Redox Signal. 2019 Apr 1;30(10):1271-1284. doi: 10.1089/ars.2017.7426. Epub 2018 Jun 11.
7
Sortilin 1 Loss-of-Function Protects Against Cholestatic Liver Injury by Attenuating Hepatic Bile Acid Accumulation in Bile Duct Ligated Mice.Sortilin 1 功能丧失可通过减轻胆管结扎小鼠肝内胆汁酸蓄积来保护胆汁淤积性肝损伤。
Toxicol Sci. 2018 Jan 1;161(1):34-47. doi: 10.1093/toxsci/kfx078.
8
Activation of necroptosis in human and experimental cholestasis.人类和实验性胆汁淤积中坏死性凋亡的激活。
Cell Death Dis. 2016 Sep 29;7(9):e2390. doi: 10.1038/cddis.2016.280.
9
Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.血清素通过减少胆管结扎后的胆汁盐池来保护小鼠肝脏免受胆汁淤积性损伤。
Hepatology. 2012 Jul;56(1):209-18. doi: 10.1002/hep.25626. Epub 2012 Jun 5.
10
A novel murine model of reversible bile duct obstruction demonstrates rapid improvement of cholestatic liver injury.一种新型的可逆性胆管梗阻小鼠模型显示胆汁淤积性肝损伤迅速改善。
Physiol Rep. 2020 May;8(10):e14446. doi: 10.14814/phy2.14446.

引用本文的文献

1
CDC6 may serve as an indicator of lung adenocarcinoma prognosis and progression based on TCGA and GEO data mining and experimental analyses.基于 TCGA 和 GEO 数据挖掘和实验分析,CDC6 可作为肺腺癌预后和进展的标志物。
Oncol Rep. 2024 Feb;51(2). doi: 10.3892/or.2024.8694. Epub 2024 Jan 8.
2
18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs.18β-甘草次酸通过靶向活化肝星状细胞中的PRDX1/2诱导活性氧介导的细胞凋亡以改善肝纤维化。
J Pharm Anal. 2022 Aug;12(4):570-582. doi: 10.1016/j.jpha.2022.06.001. Epub 2022 Jun 8.
3
Substance P Hinders Bile Acid-Induced Hepatocellular Injury by Modulating Oxidative Stress and Inflammation.

本文引用的文献

1
The Association of Peroxiredoxin 4 with the Initiation and Progression of Hepatocellular Carcinoma.过氧化物酶 4 与肝细胞癌发生和进展的关系。
Antioxid Redox Signal. 2019 Apr 1;30(10):1271-1284. doi: 10.1089/ars.2017.7426. Epub 2018 Jun 11.
2
Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease.过氧化物酶体增殖物激活受体4(PRDX4):其在从动脉粥样硬化到非酒精性脂肪性肝病等代谢综合征动物模型中的关键体内作用。
Pathol Int. 2018 Feb;68(2):91-101. doi: 10.1111/pin.12634. Epub 2018 Jan 17.
3
Bile Acid Metabolism in Liver Pathobiology.
P物质通过调节氧化应激和炎症反应来抑制胆汁酸诱导的肝细胞损伤。
Antioxidants (Basel). 2022 May 7;11(5):920. doi: 10.3390/antiox11050920.
4
Oxidation of peroxiredoxin-4 induces oligomerization and promotes interaction with proteins governing protein folding and endoplasmic reticulum stress.过氧化物酶 4 的氧化诱导其寡聚化,并促进与调节蛋白质折叠和内质网应激的蛋白质相互作用。
J Biol Chem. 2021 Jan-Jun;296:100665. doi: 10.1016/j.jbc.2021.100665. Epub 2021 Apr 23.
5
Acupuncture on ST36, CV4 and KI1 Suppresses the Progression of Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in Mice.针刺足三里穴、关元穴和太溪穴可抑制蛋氨酸和胆碱缺乏饮食诱导的小鼠非酒精性脂肪性肝病进展。
Metabolites. 2019 Dec 9;9(12):299. doi: 10.3390/metabo9120299.
肝脏病理生物学中的胆汁酸代谢
Gene Expr. 2018 May 18;18(2):71-87. doi: 10.3727/105221618X15156018385515. Epub 2018 Jan 11.
4
Cholic Acid Enhances Visceral Adiposity, Atherosclerosis and Nonalcoholic Fatty Liver Disease in Microminipigs.胆酸增强小型猪内脏脂肪堆积、动脉粥样硬化和非酒精性脂肪肝。
J Atheroscler Thromb. 2017 Nov 1;24(11):1150-1166. doi: 10.5551/jat.39909. Epub 2017 May 11.
5
Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response.胆汁酸通过触发肝细胞特异性炎症反应引发胆汁淤积性肝损伤。
JCI Insight. 2017 Mar 9;2(5):e90780. doi: 10.1172/jci.insight.90780.
6
Elevated cholesterol levels have a poor prognosis in a cholestasis scenario.在胆汁淤积的情况下,胆固醇水平升高预后较差。
J Biochem Mol Toxicol. 2017 Jan;31(1):1-6. doi: 10.1002/jbt.21831. Epub 2016 Aug 12.
7
Overexpression of Peroxiredoxin 4 Affects Intestinal Function in a Dietary Mouse Model of Nonalcoholic Fatty Liver Disease.过氧化物酶体增殖物激活受体4过表达对非酒精性脂肪性肝病饮食诱导小鼠模型肠道功能的影响
PLoS One. 2016 Apr 1;11(4):e0152549. doi: 10.1371/journal.pone.0152549. eCollection 2016.
8
Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis.小鼠胆管结扎:梗阻性胆汁淤积诱导炎症性肝损伤和肝纤维化
J Vis Exp. 2015 Feb 10(96):52438. doi: 10.3791/52438.
9
Physiological and pathological views of peroxiredoxin 4.过氧化物氧还蛋白4的生理和病理观点
Free Radic Biol Med. 2015 Jun;83:373-9. doi: 10.1016/j.freeradbiomed.2015.01.025. Epub 2015 Feb 2.
10
Differential Fmo3 gene expression in various liver injury models involving hepatic oxidative stress in mice.小鼠不同肝损伤模型中Fmo3基因表达差异与肝脏氧化应激的关系
Toxicology. 2014 Nov 5;325:85-95. doi: 10.1016/j.tox.2014.08.013. Epub 2014 Sep 2.